Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
With an FDA approval submission for RegenXBio’s Hunter syndrome gene therapy already underway, the biopharma has now ...
The deal with Nippon Shinyaku announced Tuesday will hand over partial responsibility to Regenxbio’s most advanced wholly ...
Hunter syndrome results from the absence of an enzyme needed to break down cellular waste. Without it, waste builds up in the body, causing progressive damage to various systems.